According to the enterprise survey, the controlling shareholder of Hengrui Pharma is jiangsu hengrui Pharmaceutical Group Co., Ltd. (holding 24. 15% equity of jiangsu hengrui Pharmaceutical Co., Ltd.), and the ultimate controller is Sun Piaoyang (holding 22.40% equity of jiangsu hengrui Pharmaceutical Co., Ltd.). Hengrui Pharma is an influential company in the field of medicine, but it is not a state-owned enterprise.
Driven by innovation, Hengrui Pharma is committed to developing and producing high-quality drugs to provide better treatment programs for patients around the world.